Philippines
08048030638
+917498304432

LuciGil (Gilteritinib) in London, Washington USA, Canberra Australia, Singapore and Manila

LuciGil is used to treat relapsed or refractory acute myeloid leukemia with FLT3 mutation. Active Ingredient Gilteritinib inhibits FLT3 receptor signaling. Uses of LuciGil • FLT3-positive AML How LuciGil Works It blocks FLT3 pathways responsible for cancer cell proliferation. How to Use LuciGil • Take once daily Possible Side Effects • Fatigue • Elevated liver enzymes Precautions • Monitor heart rhythm • Regular blood tests Safety Information Use under medical supervision. Storage • Store at room temperature • Protect from moisture and sunlight • Keep out of reach of children
 2026-03-24T12:14:15

Keywords